Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo's long-acting insulin degludec takes big step to megamarket status
Novo's long-acting insulin degludec takes big step to megamarket status
Novo's long-acting insulin degludec takes big step to megamarket status
Submitted by
admin
on October 19, 2012 - 12:20pm
Source:
Fierce Biotech
News Tags:
degludec
Novo Nordisk
diabetes
insulin
Europe
Tresiba
Headline:
Novo's long-acting insulin degludec takes big step to megamarket status
Do Not Allow Advertisers to Use My Personal information
